Novavax Jumps More Than 5.5% On Insider Buying

Novavax (NVAX) jumped more than 5.5% after a form 4 filing with the U.S. Securities and Exchange Commission showed CFO John Trizzino purchased 50,000 shares on May 14 at $1.6399 per share, bringing his beneficial ownership to 138,965 shares.

In a separate Form 4 filing, Gregory Glenn, president of the firm’s research and development department, purchased 100 and 19,900 shares in two tranches at $1.635 and $1.64, respectively, bringing his beneficial ownership to 47,211 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *

*